Debate: does it matter how you lower blood pressure?

por McInnes, Gordon T
Publicado 2001

The Performance of Clinics for Out-Patient Control of Anticoagulation

por McInnes, Gordon T., Helenglass, Gilla
Publicado 1987

The Unintended Consequences of Clinical Trials Regulations

por McMahon, Alex D., Conway, David I., MacDonald, Tom M., McInnes, Gordon T.
Publicado 2009

Does the aldosterone: renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study

por Parthasarathy, Hari K, Alhashmi, Khamis, McMahon, Alex D, Struthers, Allan D, Connell, John MC, McInnes, Gordon T, Ford, Ian, MacDonald, Thomas M
Publicado 2007

Prevention And Treatment of Hypertension With Algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistan...

por Williams, Bryan, MacDonald, Thomas M, Caulfield, Mark, Cruickshank, J Kennedy, McInnes, Gordon, Sever, Peter, Webb, David J, Salsbury, Jackie, Morant, Steve, Ford, Ian, Brown, Morris J
Publicado 2015

Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension

por Brown, Morris J, Williams, Bryan, MacDonald, Thomas M, Caulfield, Mark, Cruickshank, J Kennedy, McInnes, Gordon, Sever, Peter, Webb, David J, Salsbury, Jackie, Morant, Steve, Ford, Ian
Publicado 2015

Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trial

por MacDonald, Thomas M, Williams, Bryan, Caulfield, Mark, Cruickshank, J Kennedy, McInnes, Gordon, Sever, Peter, Webb, David J, Mackenzie, Isla S, Salsbury, Jackie, Morant, Steve, Ford, Ian, Brown, Morris J
Publicado 2015

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

por Williams, Bryan, MacDonald, Thomas M, Morant, Steve, Webb, David J, Sever, Peter, McInnes, Gordon, Ford, Ian, Cruickshank, J Kennedy, Caulfield, Mark J, Salsbury, Jackie, Mackenzie, Isla, Padmanabhan, Sandosh, Brown, Morris J
Publicado 2015

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomise...

por Brown, Morris J, Williams, Bryan, Morant, Steve V, Webb, David J, Caulfield, Mark J, Cruickshank, J Kennedy, Ford, Ian, McInnes, Gordon, Sever, Peter, Salsbury, Jackie, Mackenzie, Isla S, Padmanabhan, Sandosh, MacDonald, Thomas M
Publicado 2016

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies

por Williams, Bryan, MacDonald, Thomas M, Morant, Steve V, Webb, David J, Sever, Peter, McInnes, Gordon T, Ford, Ian, Cruickshank, J Kennedy, Caulfield, Mark J, Padmanabhan, Sandosh, Mackenzie, Isla S, Salsbury, Jackie, Brown, Morris J
Publicado 2018

Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial

por MacDonald, Thomas M., Williams, Bryan, Webb, David J., Morant, Steve, Caulfield, Mark, Cruickshank, J. Kennedy, Ford, Ian, Sever, Peter, Mackenzie, Isla S., Padmanabhan, Sandosh, McCann, Gerald P., Salsbury, Jackie, McInnes, Gordon, Brown, Morris J.
Publicado 2017